Centogene reports full year 2023 financial results and recent business highlights

Cambridge, mass. and rostock, germany and berlin, may 15, 2024 (globe newswire) -- centogene n.v. (nasdaq: cntg) (“we” or the “company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced financial results for the fiscal year ended december 31, 2023, and provided a business update.

CNTG Ratings Summary

CNTG Quant Ranking